The Efficacy of Computerized Cognitive Behavioral Therapy for Depressive and Anxiety Symptoms in Patients With COVID-19: Randomized Controlled Trial
Open accessPublished version of a preprint
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index; 3 of the 26 sources its claims cite were checked for support.
Abstract
Background The prevalence of depressive and anxiety symptoms in patients with COVID-19 is higher than usual. Previous studies have shown that there are drug-to-drug interactions between antiretroviral drugs and antidepressants. Therefore, an effective and safe treatment method was needed. Cognitive behavioral therapy (CBT) is the first-line psychological therapy in clinical treatment. Computerized CBT (cCBT) was proven to be an effective alternative to CBT and does not require face-to-face therapy between a therapist and the patient, which suited the COVID-19 pandemic response. Objective This study aims to evaluate the efficacy of the cCBT program we developed in improving depressive and anxiety symptoms among patients with COVID-19. Methods We customized a cCBT program focused on improving depressive and anxiety symptoms among patients with COVID-19, and then, we assessed its effectiveness. Screening was based on symptoms of depression or anxiety for patients who scored ≥7 on the Hamilton Depression Rating Scale (HAMD17) or the Hamilton Anxiety Scale (HAMA). A total of 252 patients with COVID-19 at five sites were randomized into two groups: cCBT + treatment as usual (TAU; n=126) and TAU without cCBT (n=126). The cCBT + TAU group received the cCBT intervention program for 1 week. The primary efficacy measures were the HAMD17 and HAMA scores. The secondary outcome measures were the Self-Rating Depression Scale (SDS), Self-Rating Anxiety Scale (SAS), and Athens Insomnia Scale (AIS). Assessments were carried out pre- and postintervention. The patients’ symptoms of anxiety and depression in one of the centers were assessed again within 1 month after the postintervention assessment. Results The cCBT + TAU group displayed a significantly decreased score on the HAMD17, HAMA, SDS, SAS, and AIS after the intervention compared to the TAU group (all P<.001). A mixed-effects repeated measures model revealed significant improvement in symptoms of depression (HAMD17 and SDS scores, both P<.001), anxiety (HAMA and SAS scores, both P<.001), and insomnia (AIS score, P=.002) during the postintervention and follow-up periods in the cCBT + TAU group. Additionally, the improvement of insomnia among females (P=.14) and those with middle school education (P=.48) in the cCBT + TAU group showed no significant differences when compared to the TAU group. Conclusions The findings of this study suggest that the cCBT program we developed was an effective nonpharmacological treatment for symptoms of anxiety, depression, and insomnia among patients with COVID-19. Further research is warranted to investigate the long-term effects of cCBT for symptoms of anxiety, depression, and insomnia in patients with COVID-19. Trial Registration Chinese Clinical Trial Registry ChiCTR2000030084; http://www.chictr.org.cn/showprojen.aspx?proj=49952
Overview
CoChat Summary
## TL;DR
This multicenter randomized controlled trial found that a 1-week computerized CBT program added to treatment as usual reduced depressive, anxiety, and insomnia symptoms in patients with COVID-19 compared with treatment as usual alone. The benefits were seen immediately postintervention and were still present at 1-month follow-up in the subset assessed.
## Key findings
- Among 252 analyzable patients with COVID-19 randomized 1:1 to cCBT + TAU (n=126) or TAU (n=126), the cCBT + TAU group had significantly lower postintervention scores on all primary and secondary outcomes: HAMD17, HAMA, SDS, SAS, and AIS, all P<.001.
- In the repeated-measures analysis, the cCBT + TAU group showed significant improvement over postintervention and follow-up in depression (HAMD17 and SDS, both P<.001), anxiety (HAMA and SAS, both P<.001), and insomnia (AIS, P=.002).
- At 1-month follow-up, the interaction between group and period was significant for all five scales (all P<.001), and post hoc tests showed significant reductions from baseline in the cCBT + TAU group for all five scores (all P<.05, Bonferroni-adjusted).
- Subgroup analyses found no significant between-group improvement in insomnia for females (P=.14) or for patients with middle school education (P=.48).
## Methods
- Prospective, multicenter, nonblinded, two-arm, parallel-group randomized controlled trial conducted at five hospitals in China from March 2020 to June 2020.
- Eligible participants were adults 18–75 years with mild/common COVID-19 and mild to moderate depressive or anxiety symptoms, defined as HAMD17 ≥7 or HAMA ≥7; 252 participants were analyzed after screening.
- Participants were randomized 1:1 to 1 week of cCBT + TAU or TAU alone; main analyses used t tests, subgroup analyses, and a mixed-effects model for repeated measures (MMRM) with Bonferroni post hoc testing.
## Limitations
- The paper states the trial was nonblinded, and says this, together with multiple outcomes, increased the risk of type I error.
- The paper states the sample sizes were relatively small and the follow-up time was relatively short.
- The paper states it did not account for more confounding factors such as drug side effects and related adversity.
- Evident from the text: the 1-month follow-up was done in only one center, so longer-term generalizability is limited.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
2 Valid · 0 Not valid · 16 Not checked · 32 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“CBT is the first-line psychological treatment recommended by the guidelines of depression, anxiety, and PTSD (ie, Canadian Network for Mood and Anxiety Treatments and National Institute of Health and Care Excellence guideline [49,50].”
§ The Efficacy of Computerized Cognitive Behavioral Therapy for Depressive and Anxiety Symptoms in Patients With COVID-19: Randomized Controlled Trial > Discussion > Principal Results
What the sources say
- Partly supportedcites [49] sourceExperimental — accuracy not yet measured
Our copy of CANMAT 2016 Section 2 fully supports the depression component: Table 5 lists CBT as first line for both acute treatment and relapse-prevention maintenance (Level 1), and section 2.10 states 'CBT has Level 1 Evidence and is recommended as a first-line maintenance therapy' as well as first-line for acute MDD. However, the Abstract states 'The scope of these guidelines remains the management of adults with unipolar major depressive disorder (MDD)', and no passage makes any first-line recommendation for anxiety disorders or PTSD; the only anxiety-related content is section 2.3, which summarises evidence on comorbid anxiety in depression ('insufficient evidence to define formal treatment recommendations'). The anxiety and PTSD components of the claim are therefore not supported by this source (they would rest on the companion NICE citation). (LLM, conf=0.85)
- Not checked yetcites [50] Post-traumatic stress disorderThe National Institute for Health and Care Excellence2020-12-15https://www.nice.org.uk/guidance/ng116
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Computerized CBT (cCBT) was proven to be an effective alternative to CBT and does not require face-to-face therapy between a therapist and the patient, which suited the COVID-19 pandemic response.”
- Also stated in: § Introduction · boosted
“There is substantial evidence that cCBT is an effective alternative to CBT for the treatment of mild to moderate depression and anxiety [18-20].”
§ The Efficacy of Computerized Cognitive Behavioral Therapy for Depressive and Anxiety Symptoms in Patients With COVID-19: Randomized Controlled Trial > Abstract > Background
What the sources say
- Partly supportedcites [18] sourceExperimental — accuracy not yet measured
The DISCUSSION (p. Results/Discussion) and abstract report the trial's core finding — noninferiority of clinician-supported CCBT versus a full 16-week/20-session standard CBT course in 154 drug-free patients with major depressive disorder, with comparable completion and remission rates (week 16 HAMD 8.9 vs 9.2, d=0.05) — which supports 'effective alternative to CBT' for depression. However, the population qualifiers are not supported: the METHODS exclusion criteria removed patients with a primary anxiety disorder, entry required HAMD ≥14, and RESULTS (Patient Characteristics) note nearly 50% scored ≥20 with over half chronic, so this is neither an anxiety study nor a mild-depression sample; the paper only cites meta-analyses (refs 20–24) for CCBT's broader efficacy. The citing sentence's added claim that cCBT 'does not require face-to-face therapy' runs against our copy, which states 'We only provided face-to-face therapist support in this investigation' (DISCUSSION) and that stand-alone unsupported programs 'typically have much smaller effects' with 'some amount of clinical support is important' (INTRODUCTION). (LLM, conf=0.78)
- Not checked yetcites [19] source
- Partly supportedcites [20] sourceExperimental — accuracy not yet measured
Our copy supports the anxiety half of the claim: the Abstract Conclusions and Discussion (post-treatment outcomes) report that both clinician- and technician-assisted iCBT for DSM-IV GAD gave large effect sizes (PSWQ 1.16/1.07; GAD-7 1.55/1.73) 'comparable to those associated with face-to-face treatment' and to meta-analyses of face-to-face CBT for GAD. It does not support the depression indication: depression was only a secondary measure (PHQ-9) in GAD participants, and the Methods (Participants) screened out people with severe depression rather than recruiting a 'mild to moderate depression' sample, so the paper is not evidence that cCBT is an effective alternative to CBT for depression. The claim's generalization across 'mild to moderate depression and anxiety' therefore exceeds this single GAD trial. (LLM, conf=0.75)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Introduction · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The cCBT + TAU group displayed a significantly decreased score on the HAMD17, HAMA, SDS, SAS, and AIS after the intervention compared to the TAU group (all P<.001).”
- Also stated in: § Results · plain
“Compared to the TAU group, the cCBT + TAU group showed significant improvement in both the primary outcomes of HAMD17 and HAMA scores and the secondary outcomes of SDS, SAS, and AIS scores (all P<.001).”
§ The Efficacy of Computerized Cognitive Behavioral Therapy for Depressive and Anxiety Symptoms in Patients With COVID-19: Randomized Controlled Trial > Abstract > Results
plainstates a causen = 252- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As demonstrated in Table 4, a significant difference in the interaction between groups and periods (all P<.001) was observed in all scale scores.”
§ The Efficacy of Computerized Cognitive Behavioral Therapy for Depressive and Anxiety Symptoms in Patients With COVID-19: Randomized Controlled Trial > Results
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Additionally, the improvement of insomnia among females (P=.14) and those with middle school education (P=.48) in the cCBT + TAU group showed no significant differences when compared to the TAU group.”
- Also stated in: § Results · plain
“For female patients, we found no evidence of significant between-group differences for the change of AIS scores (Table S1 in Multimedia Appendix 1).”
§ The Efficacy of Computerized Cognitive Behavioral Therapy for Depressive and Anxiety Symptoms in Patients With COVID-19: Randomized Controlled Trial > Abstract > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
20 more claims
Create a free account to see all 50 claims and to verify the 23 references still open.
- The quote only partly states this claim. 1
- Probably not a substantial claim. 15
- It may state two separate claims as one. 14
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Only the RCT on cCBT found reductions in depressive symptoms post-intervention [20].”
From Promoting Recovery from Disasters, Pandemics, and Trauma: A Systematic Review of Brief Psychological Interventions to Reduce Distress in Adults, Children, and Adolescents (2023) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both studies reported significant reductions in anxiety at one-month follow-up after the application of cCBT [20] and post-training after the application of the Individualized Short-term Training Program [21].”
From Promoting Recovery from Disasters, Pandemics, and Trauma: A Systematic Review of Brief Psychological Interventions to Reduce Distress in Adults, Children, and Adolescents (2023) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The intervention was tested in an RCT during the COVID-19 pandemic in China with N = 252 adult COVID-19-infected patients [20].”
The cited source says what the claim attributes to it.
In the citing paper
“A significant decrease in depressive and anxiety symptoms was found at one-month follow-up in the cCBT + treatment as usual (TAU) group compared to a TAU-only group”
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 1×
“For HAMD 17 [30], items are scored on a 5-point Likert scale (0-4) for a total score range from 0 to 68, with higher scores indicating more depressive symptoms.”
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969 · cited 1×
“COVID-19, caused by a novel coronavirus (SARS-CoV-2) [5], continues to spread worldwide.”
Self-citationThe assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455 · cited 1×
“Similarly, HAMA [31] consists of 14 items on a 5-point Likert scale (0-4) for a total score range from 0 to 56, with higher scores indicating more anxiety symptoms.”
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
Rothan, H. A., & Byrareddy, S. N. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102433 · Cited by 5,840 · cited 1×
“…effects of physical and psychological distress have increased with each successive public health emergency, such as with the severe acute respiratory syndrome (SARS) in 2003 [1], the Middle East Respiratory Syndrome (MERS) [2] in 2012, the Ebola virus disease in 2014 [3], and COVID-19 in 2020 [4].”
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643 · cited 1×
“Moreover, only an approximate 33% of the patients were clinically cured [46], and these demonstrated residual symptoms following acute treatment [47].”
Guo (2020) · doi:10.1186/s40779-020-00240-0 · Cited by 4,735 · cited 1×
“The common clinical symptoms of patients with COVID-19 include cough, fever, fatigue, hypoxia, and occasionally gastrointestinal infection [12].”
WHO Coronavirus Disease (COVID-19) Dashboard
(2020) · Bangladesh Physiotherapy Journal · doi:10.46945/bpj.10.1.03.01 · Cited by 3,806 · cited 1×
“At present, there have been nearly 30 million confirmed cases and nearly 1 million deaths worldwide [7].”
Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed
Xiang, Y.-T., Yang, Y., Li, W., Zhang, L., Zhang, Q., Cheung, T., & Ng, C. H. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30046-8 · Cited by 3,598 · cited 2×
“…including but not limited to drug side effects, a fear of severe disease consequences, a fear of infecting others, and an inability to get correct information in a timely manner [13]—all of which may lead to several psychological distresses including anxiety, depression, and insomnia [8,14].”
Self-citationCOVID-19 pandemic and mental health consequences: Systematic review of the current evidence
Vindegaard, N., & Benros, M. E. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.05.048 · Cited by 3,221 · cited 1×
“Moreover, evidence from epidemiological studies revealed the relationship between gender, age, education level, and severity of mental problems [24].”
Velavan, T. P., & Meyer, C. G. (2020) · Tropical Medicine & International Health · doi:10.1111/tmi.13383 · Cited by 2,439 · cited 1×
“On January 30, 2020, the World Health Organization Emergency Committee declared a global health emergency based on growing case notification rates at Chinese and international locations [6].”
Research works printed but not linked: 5
- Bisson, JI, 2010, BMJ Clin Evid, 2010, 1005
- Li, CE, 2006, Adolescence, 41, 409
- Yuan, M, 2016, Sichuan Da Xue Xue Bao Yi Xue Ban, 47, 898
- 10.13798/j.issn.1009-153x.2020.08.011 · doi:10.13798/j.issn.1009-153x.2020.08.011
- 10.3969/j.issn.2095-8552.2020.11.028 · doi:10.3969/j.issn.2095-8552.2020.11.028
Cited by
Depression and Anxiety During the COVID-19 Pandemic: Epidemiology, Mechanism, and Treatment
Zhu, C., Zhang, T., Li, Q., Chen, X., & Wang, K. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00970-2 · Cited by 185
“Recent studies have shown that CBT was effective at relieving depressive and anxiety symptoms in patients with COVID-19 [75, 84, 85].”
BackgroundKim, J., Aryee, L. M. D., Bang, H., Prajogo, S., Choi, Y. K., Hoch, J. S., & Prado, E. L. (2023) · JMIR Mental Health · doi:10.2196/43066 · Cited by 106
“More information about the included studies is available in Multimedia Appendix 6 [26-121].”
BackgroundInfluentialEfficacy of Pulmonary Rehabilitation in Post-COVID-19: A Systematic Review and Meta-Analysis
Oliva, E. M., Martínez‐Pozas, O., Cuenca‐Zaldívar, J. N., Villafañe, J. H., Jiménez‐Ortega, L., & Romero, E. A. S. (2023) · Biomedicines · doi:10.3390/biomedicines11082213 · Cited by 88
“However, considering that mental health disorders in patients with COVID-19 showed prevalence rates of 16% in terms of depression or 15% in terms of anxiety [82], and seeing that psychological therapies such as cognitive behavioral therapy had shown positive effects improving anxiety and depression in patients with CO…”
Wang, Y., Li, X., Zhang, Q., Yeung, D. Y.-L., & Wu, Y. (2025) · JMIR mhealth and uhealth · doi:10.2196/63806 · Cited by 76
Self-citationKomariah, M., Amirah, S., Faisal, E. G., Prayogo, S. A., Maulana, S., Platini, H., Suryani, S., Yosep, I., & Arifin, H. (2022) · Healthcare · doi:10.3390/healthcare10071224 · Cited by 70
“(2021) [34] China RCT 326 Female (102) Male(150) IG: 43.”
Non-Pharmacological Therapies for Post-Viral Syndromes, Including Long COVID: A Systematic Review
Chandan, J. S., Brown, K. R., Simms-Williams, N., Bashir, N. Z., Camaradou, J., Heining, D., Turner, G., Rivera, S. C., Hotham, R., Minhas, S., et al. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043477 · Cited by 62
Ye, Z., Li, W., & Zhu, R. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.08.023 · Cited by 56
Anser, M. K., Nabi, A. A., Ahmad, I., Abro, M. M. Q., & Zaman, K. (2025) · Health care science · doi:10.1002/hcs2.70018 · Cited by 46
Effect of resistance training on heart rate variability of anxious female college students
Li, R., Yan, R., Cheng, W., & Ren, H. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1050469 · Cited by 41
The COVID-19 pandemic increased poor lifestyles and worsen mental health: a systematic review.
Zhao, Z., Lu, L., & Sang, Y. (2023) · PubMed Central · Cited by 38
Lotzin, A., Franc de Pommereau, A., & Laskowsky, I. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20075339 · Cited by 36
“(2021) [20] Computerized Cognitive Behavioral Therapy (cCBT) [20]: Online self-help cCBT targeting patients with COVID-19 A total of three modules: cognitive training, cognitive consolidation, and behavioral therapy Introduction to the program by a therapist RCT (Intervention + TAU vs.”
BackgroundMethodInfluentialLi, G., Shi, W. X., Gao, X., Shi, X., Feng, X., Liang, D., Li, C., Phillips, M. R., & Hall, B. J. (2022) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2022.100580 · Cited by 36
Huang, J., Fan, Y., Zhao, K., Yang, C., Zhao, Z., Chen, Y., Yang, J., Wang, T., & Qu, Y. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.954754 · Cited by 35
Zamiri-Miandoab, N., Hasanzadeh, R., & Mirghafourvand, M. (2022) · Annals of General Psychiatry · doi:10.1186/s12991-022-00417-y · Cited by 35
Yang, Y., Zhang, H., Li, Y., Liu, Z., Liu, S., Li, X., Fan, G., Xu, Y. J., & Wang, B. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.12.068 · Cited by 33
Self-citationWatson, P. (2022) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-021-00253-z · Cited by 33
Wang, Q., Zhang, B., Zhang, S., Wei, C., Fu, D., Zhao, H., & Bai, X. (2022) · BMC Medical Education · doi:10.1186/s12909-022-03839-0 · Cited by 32
“Supplementary Material 1 Acknowledgements The authors would like to thank the all researchers and student leaders who organized the distribution and collection of the questionnaires in their classrooms as well as the students for their participation.”
MethodInfluentialLin, Z., Cheng, L., Han, X., Wang, H., Liao, Y., Guo, L., Shi, J., Fan, B., Teopiz, K. M., Jawad, M. Y., et al. (2023) · Journal of Medical Internet Research · doi:10.2196/42786 · Cited by 31
“Some studies implemented ICBT in Chinese patients before and after surgery to reduce anxiety and depressive symptoms [21,22], and some implemented ICBT to alleviate the anxiety and distress of people during the COVID-19 epidemic [23-25].”
Xiao, W., Liu, X., Wang, H., Huang, Y., Dai, Z., Si, M., Fu, J., Chen, X., Jia, M., Leng, Z., et al. (2023) · Infectious Diseases of Poverty · doi:10.1186/s40249-023-01074-3 · Cited by 30
“A randomized controlled trial also suggested that computerized cognitive behavioral therapy was an effective nonpharmacological treatment for symptoms of anxiety, depression, and insomnia among COVID-19 patients [49].”
BackgroundKariri, H. D. H., & Almubaddel, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37763 · Cited by 29
Yan, Z., Yang, M., & Lai, C. (2023) · Viruses · doi:10.3390/v15020533 · Cited by 29
Post-sepsis psychiatric disorder: Pathophysiology, prevention, and treatment
Li, D., Zhang, X., Lu, Y., Liang, J., Hu, H., Song, Y., Wu, S., & Zhu, W. M. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07409-8 · Cited by 27
“Additionally, computerized cognitive behavioral therapy (cCBT) and progressive muscle relaxation training can greatly improve depression, anxiety, and sleep quality in COVID-19 patients [89, 90].”
BackgroundWang, X., Xia, F., & Wang, G. (2023) · BMC Psychology · doi:10.1186/s40359-023-01169-4 · Cited by 26
“CCBT is psychotherapy that changes patients’ thinking or behavior through computer interactive interface, combined with web pages, cartoons, animations, videos, sound and other highly structured media interactions [48].”
BackgroundWang, M., Chen, H., Yang, F., Xu, X., & Li, J. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.06.057 · Cited by 25
Li, Q., Zhang, L., Chen, C., Gan, Y., Jiang, L., Li, S., Xiang, W., Ming, Y., Yang, C., & Zhou, J. (2022) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2021.11.012 · Cited by 24
Wang, S., Gao, L., Wang, C., Bai, J., Shen, M., Zhao, X., & Lin, M. F. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1433558 · Cited by 22
He, J., Lin, J., Sun, W. J., Cheung, T. C. C., Cao, Y., Fu, E., Chan, S. H., & Tsang, H. W. H. (2023) · Scientific Reports · doi:10.1038/s41598-023-45839-0 · Cited by 22
Benefits of Urban Forest Healing Program on Depression and Anxiety Symptoms in Depressive Patients
Yeon, P., Kang, S.-N., Lee, N.-E., Kim, I.-O., Min, G.-M., Kim, G.-Y., Kim, J.-G., & Shin, W.-S. (2023) · Healthcare · doi:10.3390/healthcare11202766 · Cited by 21
Zheng, Q., Liu, F., Xu, S., Hu, J., Lu, H., & Liu, T. (2023) · Journal of Safety Science and Resilience · doi:10.1016/j.jnlssr.2023.10.002 · Cited by 19
A digital intervention for cognitive deficits following COVID-19: a randomized clinical trial
Victoria, L. W., Oberlin, L. E., Ilieva, I. P., Jaywant, A., Kanellopoulos, D., Mercaldi, C. J., Stamatis, C. A., Farlow, D., Kollins, S. H., Tisor, O., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01995-z · Cited by 18
Yin, Z.-H., Bao, Q.-N., Li, Y., Liu, Y., Wang, Z.-Q., Ye, F., He, X., Zhang, X., Zhong, W., Wu, K., et al. (2024) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2024.103118 · Cited by 18
Anxiety in post-covid-19 syndrome – prevalence, mechanisms and treatment
Burkauskas, J., Branchi, I., Pallanti, S., & Domschke, K. (2023) · Neuroscience Applied · doi:10.1016/j.nsa.2023.103932 · Cited by 16
Shi, Y., Guo, H., Du, Y.-Z., Wang, J., Shang, Y., & Wang, Y. (2023) · PubMed Central · Cited by 16
Self-citationDoherty, A., Benedetto, V., Harris, C., Boland, P., Christian, D. L., Hill, J., Bhutani, G., & Clegg, A. J. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03602-7 · Cited by 15
“Various psychological interventions have been used: therapist-guided therapy (n = 1); online counselling (n = 1); ‘Emotional Freedom Techniques’ (n = 1); mobile phone apps (n = 2); brief crisis intervention (n = 1); psychological-behavioural intervention (n = 1); Cognitive Behavioural Therapy (n = 3); progressive musc…”
BackgroundInfluentialKurniawan, K., Yosep, I., Maulana, S., Mulyana, A. M., Amirah, S., Abdurrahman, M. F., Sugianti, A., Putri, E. G., Khoirunnisa, K., Komariah, M., et al. (2022) · Sustainability · doi:10.3390/su141912866 · Cited by 14
“(2021) [14] China RCT m-CBT HAMA COVID-19 patients IG: 43.”
BackgroundTrait Anxiety Mediates Impulsivity and Suicidal Ideation in Depression During COVID-19 Pandemic
Cheng, X., Zhang, Y., Zhao, D., Yuan, T., & Qiu, J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.892442 · Cited by 14
Chennapragada, L., Sullivan, S. R., Hamerling-Potts, K. K., Tran, H., Szeszko, J., Wrobleski, J., Mitchell, E. L., Walsh, S., & Goodman, M. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114748 · Cited by 13
Ferreira, C. C. Q., Lima, K. R., Dias‐Peixoto, M. F., Orlando, D. R., Castelo, P. M., Pereira, L. J., & Andrade, E. F. (2024) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2024.05.015 · Cited by 13
Recent Advancements on Long COVID in China: A Narrative Review
Tang, J., Song, T., Kuang, M., Feng, Y., Liu, G., & Liu, H. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s417692 · Cited by 13
“Mental Health Interventions Cognitive behavioral therapy (CBT) is recommended as a first-line psychological treatment for clinical therapy.(52) Studies have shown that the mean decreases in depression, anxiety, stress, and total DASS-21 scores were greater in the CBT intervention group than in the control group, highl…”
BackgroundMethodWang, S., Luo, G., Pan, D., Ding, X., Yang, F., Zhu, L., Wang, S., & Ma, X. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1323303 · Cited by 13
Jiang, M., Yu, Y. J., Zhao, Q., Li, J., Song, C., Qi, H., Zhai, W., Luo, D., Wang, X., Fu, G., et al. (2024) · arXiv (Cornell University) · doi:10.48550/arxiv.2404.11449 · Cited by 13
“This innovative CCBT tool compensates to some extent for the limitations of traditional CBT, which requires face-to-face implementation [31].”
MethodExploring the Use of Mobile Health for the Rehabilitation of Long COVID Patients: A Scoping Review
Daniels, K., Mourad, J., & Bonnechère, B. (2024) · Healthcare · doi:10.3390/healthcare12040451 · Cited by 12
“Nevertheless, the precise mechanisms through which these interventions exert their effects in various populations and environments are not fully comprehended.”
BackgroundJebrini, T., Thomas, A., Sachenbacher, S., Heimkes, F., Karch, S., Goerigk, S. A., Ruzicka, M., Fonseca, G. J. I., Wunderlich, N., Benesch, C., et al. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01904-x · Cited by 12
Technology-based cognitive behavioral therapy interventions
Newby, J. M., Upton, E., Mason, E., & Black, M. (2024) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2024.02.004 · Cited by 11
Wei, F., Yang, X., He, R., Hu, Z., & Wang, Y. (2024) · Cancer Nursing · doi:10.1097/ncc.0000000000001356 · Cited by 11
Self-citationA Dynamic Autocatalytic Network Model of Therapeutic Change
Ganesh, K., & Gabora, L. M. (2022) · Entropy · doi:10.3390/e24040547 · Cited by 12
“In addition, using RAF networks to precisely model the psychotherapeutic process could be informative in the design and execution of computerized psychotherapies [90,91], or as an aid to the human psychotherapist for keeping track of, and visually depicting, specific interactions in the psychotherapy process and their…”
MethodAraújo, D. D. F., & Costa, E. L. (2021) · Revista Brasileira de Terapias Cognitivas · doi:10.5935/1808-5687.20210015 · Cited by 11
“BRV: Baixo Risco de Viés.”
BackgroundInfluentialWork Disability Prevention and Management
Kertay, L., Caruso, G. M., Baker, N. A., Christian, J. B., Cook, J. L., Das, R., Goertz, M., McKenzie, J. G., Martin, D. W., Melhorn, J. M., et al. (2025) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000003320 · Cited by 10
Yang, L., Qin, Z., Yao, J., Xu, H., Tian, J., Ren, Y., Wang, H., & Meng, W. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1400061 · Cited by 10
Martínez‐Borba, V., Martínez‐García, L., Péris-Baquero, Ó., Osma, J., & Corral-Beamonte, E. D. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1305463 · Cited by 10
Tuna, Ö., & Ermiş, Ç. (2022) · Psychiatria Danubina · doi:10.24869/psyd.2022.564 · Cited by 10
“They also explained associations between cognitions and behaviors (Liu et al. 2021, de la Fuente et al. 2021, Luik et al. 2019).”
BackgroundSensa Mobile App for Managing Stress, Anxiety, and Depression Symptoms: Pilot Cohort Study
Valinskas, S., Nakrys, M., Aleknavičius, K., & Jonusas, J. (2023) · JMIR Formative Research · doi:10.2196/40671 · Cited by 10
“Finally, a randomized controlled study by Liu et al [41] reported that CBT-based computer programs used concurrently with the usual treatment statistically significantly demonstrated a greater reduction of depression and anxiety symptoms in comparison with that of standard treatment only (measure tools and differences…”
MethodInfluentialD’Onofrio, G., Trotta, N., Severo, M., Iuso, S., Ciccone, F., Prencipe, A. M., Nabavi, S. M., De Vincentis, G., & Petito, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113209 · Cited by 9
“89) on mental health condition with a decrease in depression and anxiety symptoms [21,24,25], functional and attention deficits [21], and traumatic symptoms [24].”
BackgroundInfluentialExploring the psychological impact of long COVID: symptoms, mechanisms, and treatments
Shen, S., Zhao, X., Pei, J., Wang, B., Hou, J., Chai, R., Guo, Y., Li, F., Hao, J., & Wu, Z. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1555370 · Cited by 9
Teixido, L., Andreeva, E., Gartmann, J., Lemhöfer, C., Sturm, C., & Gutenbrunner, C. M. (2022) · Physikalische Medizin Rehabilitationsmedizin Kurortmedizin · doi:10.1055/a-1820-7396 · Cited by 9
Zhou, X., Zhang, G., Chen, D., Yao, H., & Wang, Q. (2025) · Medicine · doi:10.1097/md.0000000000041401 · Cited by 9
“The pain level of patients was assessed using VAS [11] before the intervention (2) The self-rating anxiety scale [12] was used to evaluate the patients’ anxiety state before and 72 hours post-intervention.”
Tasleem, A., Wang, Y., Li, K., Jiang, X., Krishnan, A., He, C., Sun, Y., Wu, Y., Fan, S., Boruff, J. T., et al. (2022) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2022.04.002 · Cited by 9
“Participants in only 4 trials were required to have mental health symptoms as part of inclusion criteria [30,34,43,60].”
Self-citationWang, S., Zhang, Y., Ding, W., Meng, Y., Hu, H., Guan, Y., Zeng, X., Liu, Z., Meng, F., Wang, M., et al. (2025) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796025100243 · Cited by 8
“…could be a non-negligible barrier for face-to-face psychological interventions, an important lesson was the growing evidence of remotely computerized or video-conferencing delivered interventions during COVID-19, which guides more safety measures (Bryant et al. , 2022; Liu et al. , 2021).”
Self-citationYe, X., Zheng, S., Huang, X., & Yan, Q. (2023) · PubMed Central · Cited by 8
Psychological differences in adults with and without a COVID-19 diagnosis
da Graca, B., Bennett, M., Powers, M. B., Gottlieb, R., Waddimba, A. C., & Warren, A. M. (2022) · Journal of Mental Health · doi:10.1080/09638237.2021.2022617 · Cited by 8
“…workers were more likely to experience moderate or severe depression than healthcare workers during the first six months of the COVID-19 pandemic (Magalhaes et al., 2021), although, among healthcare workers, similar to the international study results, individuals with confirmed or suspected…”
ResultDevelopment and validation of a model for predicting the risk of suicide in patients with cancer
Du, L., Shi, H., Qian, Y., Jin, X., Yu, H., Fu, X., Wu, H., & Chen, H. (2022) · Archives of Suicide Research · doi:10.1080/13811118.2022.2035289 · Cited by 8
“In this study, anxiety was measured validated the effective Chinese version of the SAS scale, which has been widely used in China (Z. Liu et al., 2021; W. Xu, Tang, & Chen, 2021).”
MethodMohapatra, S., Kumar, P. A., Farooq, U., Jain, P., Khan, R., Hassan, N., Shamim, A., Ansari, M. J., Alalaiwe, A. S., Aldawsari, M. F., et al. (2022) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2022.05.004 · Cited by 8
Copyright as a Barrier to Music Therapy Telehealth Interventions: Qualitative Interview Study
Reid, A., & Kresovich, A. (2021) · JMIR Formative Research · doi:10.2196/28383 · Cited by 8
“Research also suggests web-based services are promising avenues to increase mental health awareness and treatment options [16,17].”
BackgroundLong COVID-19 Enigma: Unmasking the Role of Distinctive Personality Profiles as Risk Factors
Amsterdam, D., Kupershmidt, A., Avinir, A., Matalon, R., Ohana, O., Feder, O., Shtrozberg, S., Choshen, G., Ablin, J. N., & Elkana, O. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13102886 · Cited by 7
“The group clustering outlined in the current study holds the potential for developing patient-specific treatment plans tailored to the needs of Long COVID patients, based on their coping style [53,54].”
MethodTeixido, L., Andreeva, E., Gartmann, J., Lemhöfer, C., Sturm, C., & Gutenbrunner, C. M. (2023) · Laryngo-Rhino-Otologie · doi:10.1055/a-1985-0450 · Cited by 7
“Aktuelle Studien zur Wirksamkeit von verhaltenstherapeutischen Konzepten bei subjektiver Belastung der Betroffenen durch Angst- und Depressionssymptome [57, 58], Schlafstörungen [45, 53], Stressbelastung [73], Fatigue [70] und posttraumatischer Belastungsstörung [24, 25] geben erste Hinweise.”
BackgroundChen, R., Wang, D., Chen, Z., Li, J., Zhang, C., Xu, C., Wang, Y., & Li, R. (2024) · Scientific Reports · doi:10.1038/s41598-024-69949-5 · Cited by 7
Self-citationImpact of COVID-19 on Anxiety and Depression - Biopsychosocial Factors
Bertollo, A. G., Galvan, A. C. L., Mingoti, M. E. D., Dallagnol, C., & Ignácio, Z. M. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230210100048 · Cited by 8
Wu, Y., Zhou, D., Fornah, L., Liu, J., Zhao, J. F., & Wu, S. (2025) · Neurorehabilitation and neural repair · doi:10.1177/15459683251329893 · Cited by 6
Self-citationLi, Y., Liu, Y., Liu, X., Zhang, T., Guo, Z., Lai, L., Zhao, J., Cheng, Y., & Ren, Z. (2025) · Health Psychology Review · doi:10.1080/17437199.2025.2493903 · Cited by 6
“Since the onset of the COVID-19 pandemic, the mental health of worldwide individuals was signi fi - cantly a ff ected (Liu et al., 2021a; Robinson et al., 2022).”
InfluentialSelf-citationCharacteristics of Depression Clinical Trials Registered on ClinicalTrials.gov
Liang, J., He, P., Wu, H., Xu, X., & Ji, C. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s394143 · Cited by 6
“a first-line psychological treatment can effectively improve the symptoms of moderate depression.(26) The maximal proportion of behavioral intervention trials was 39.”
BackgroundD’Onofrio, G., Ciccone, F., Placentino, G., Placentino, M., Tulipani, C., Prencipe, A. M., & Vincentis, G. D. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19095425 · Cited by 6
Kai, S., Zhou, R., Xu, F., Lu, H., & Asakawa, T. (2024) · Global Health & Medicine · doi:10.35772/ghm.2023.01102 · Cited by 5
Han, Q., Wu, F.-R., Hong, Y., Gu, L.-L., & Zhu, Y. T. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i21.4518 · Cited by 5
“Each scale had a maximum score of 20; higher scores represent more severe symptoms[15].”
Vulnerable individuals and changes in suicidal behaviour during the COVID-19 pandemic in Korea
Lee, G. E., Kim, J. W., Lee, K. R., Hong, D. Y., Park, S. O., Kim, S. Y., Baek, K. J., & Jeon, H. J. (2022) · BJPsych Open · doi:10.1192/bjo.2022.569 · Cited by 5
“37,38 In addition, maintenance of social linkages with these individuals can reduce the threat of suicide, even if social distancing or isolation is inevitably necessary.”
BackgroundLiu, H., Zhou, Z., Liu, Y., Tao, X., Zhan, Y., & Zhang, M. (2023) · Medical science monitor basic research/Medical science monitor. Basic research · doi:10.12659/msmbr.938633 · Cited by 5
“A study showed that the cCBT program developed by Zhifen Liu was an effective nonpharmacological treatment for depressive symptoms of COVID-19 patients [16].”
Internet-based Cognitive Behavior Therapy untuk Mengurangi Kecemasan Sosial pada Dewasa Awal
Wulandari, I. I. (2024) · Gadjah Mada Journal of Professional Psychology (GamaJPP) · doi:10.22146/gamajpp.86979 · Cited by 5
Jung, J. H., & Ko, J. Y. (2024) · BMC Psychology · doi:10.1186/s40359-024-02159-w · Cited by 5
“The PHQ-9 scores (E = 2.539, p = .0.171) showed no significant interactions in the time × group analysis intervention [30].”
InfluentialLiu, K., Shi, Z.-Y., Song, Y.-K., Wang, J., Jiang, H., Zhou, X., Liu, J., Liu, J.-P., & Liu, Z. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157351 · Cited by 4
Self-citationZhai, P., Liu, H., Zhang, Y., Huang, T., Xiong, C., Liu, Y., Wang, G., Chen, X., Tan, J., Jiao, C., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1193266 · Cited by 4
Carrijo, M. D. M., Oliveira, M. C., Canedo, W. A. O., Afonso, J. P. R., Paixão, H. N. C., Alves, L. R., da Palma, R. K., Silva, I. O., Silva, C. H. M., de Oliveira, R. F., et al. (2025) · COVID · doi:10.3390/covid5110184 · Cited by 3
“These findings correspond with those reported in a cohort of Chinese patients whose therapeutic effect was associated with a significant reduction in behavioral changes [56].”
Xu, W. (2024) · Journal of Education Humanities and Social Sciences · doi:10.54097/6pyw9v48 · Cited by 3
“It also showed notable improvement in symptoms of depression, anxiety, and insomnia in follow-up and after-intervention phases in the TAU+cCBT group [10].”
BackgroundLi, L., Wan, A., Zhao, M., Yu, L., Han, Y., & Mi, K. (2024) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.41.1.9835 · Cited by 3
Psychological rehabilitation: cognitive behavioral therapy
Солохина, Т. А., & Михайловна, Л. Е. (2025) · Реабилитология. · doi:10.17749/2949-5873/rehabil.2024.27 · Cited by 3
Saleha, N., Delfina, R., Nurlaili, N., Ardiansyah, F., & Nafratilova, M. (2021) · Unnes Journal of Public Health · doi:10.15294/ujph.v10i2.42861 · Cited by 3
Sheykhangafshe, F. B., Fathi-Ashtiani, A., Niri, V. S., Zangir, M. J., & Bourbour, Z. (2023) · Modern Care Journal · doi:10.5812/modernc-131399 · Cited by 3
Alavi, S. S., Ghanizadeh, M., Sotoudeh, H. G., Mohammadi, M. R., Jannatifard, F., & Khaleghi, A. (2024) · Journal of Iranian Medical Council · doi:10.18502/jimc.v7i2.15042 · Cited by 2
Wei, X., Zhang, W., Zhang, X., Sui, Y., Yu, W., & Yuan, Y. (2023) · PubMed Central · Cited by 2
Sugita, S., Hata, K., Kodaiarasu, K., Takamatsu, N., Kimura, K., Miller, C., Gonzalez, L., Umemoto, I., Murayama, K., Nakao, T., et al. (2024) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.223 · Cited by 2
“22 Studies have also reported the efficacy of eye movement desensitization and reprocessing 23 (EMDR) and narrative exposure therapy 24 for PTSD symptoms.”
BackgroundMethodInfluence of Continuous Nursing Intervention on Treatment Compliance of Patients with Depression
He, Y., He, J., & Hou, X. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/7080678 · Cited by 2
RetractedHuang, J., Qiao, X., Song, K., Liu, R., Huang, S., He, J., Zhu, S., Reinhardt, J. D., & He, C. (2024) · Clinical Rehabilitation · doi:10.1177/02692155241239881 · Cited by 2
Yirdaw, B. A., Sunglao, J. A., Alkasaby, M. A., & Eaton, J. (2025) · Cambridge Prisms Global Mental Health · doi:10.1017/gmh.2025.22 · Cited by 2
“…the State Anxiety Scale (Dincer and Inan-gil, 2021) Self-rating Anxiety Scale (Fan et al., 2021; Li et al., 2023), Hamilton Anxiety Rating Scale (Liu et al., 2021), COVID-19 Anxiety Questionnaire (Shabahang et al., 2021), Short Anxiety Inventory (Shabahang et al., 2021), State Trait Anxiety…”
InfluentialJeong, H. N., & Chang, S. J. (2025) · Geriatric Nursing · doi:10.1016/j.gerinurse.2025.103457 · Cited by 2
Time-dependent affective disturbances in abstinent patients with methylphenidate use disorder
Xu, J., Zhang, Y., Wang, N., Sun, P., Mao, F., & Yuan, T. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04187-5 · Cited by 2
“Hamilton Anxiety Rating Scales (HARS) [21] is widely used in assessing the anxiety severity [20, 22].”
BackgroundMethodPereira, E. B., de Brito, N. F. C., & Campos, E. D. M. (2023) · Research Society and Development · doi:10.33448/rsd-v12i1.38897 · Cited by 2
Alkasaby, M. A., Philip, S., Douba, Z., Tu, H., Eaton, J., Mohammed, M., Essar, M. Y., Kamal, M. A., Riaz, M. M. A., Moussallem, M., et al. (2023) · medRxiv · doi:10.1101/2023.07.27.23293219 · Cited by 2
“, 2021)(52) A self-help intervention delivered through 10 min of self-directed individual therapy per day for 1 week.”
MethodInfluentialA community‐based cross‐sectional study of anxiety and metabolic syndrome
Liu, F., Hu, X., Zhu, X., Dong, X., Ge, J., Xu, S., Li, G., Li, L., Li, S., & Wei, Z. (2023) · Psychogeriatrics · doi:10.1111/psyg.12953 · Cited by 1
China: Confucian Harmony and Dissonance
Fogel, B. S., & Jiang, X. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780190850074.003.0010 · Cited by 1
Depression and Suicide in the “World’s Happiest Countries”
Fogel, B. S., & Jiang, X. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780190850074.003.0013 · Cited by 1
Aminoff, V., Björklund, M., Ekström, E., Stenback, A., Yousafzai, U., Berg, M., Ludvigsson, M., & Andersson, G. (2025) · Frontiers in Digital Health · doi:10.3389/fdgth.2025.1504217 · Cited by 1
Intervenções psi em hospital durante a pandemia COVID-19: Uma revisão de literatura
Costa, M. M. T., & Aires, S. (2025) · Revista Subjetividades · doi:10.5020/23590777.rs.v25i1.e14796 · Cited by 1
Metadata
- Authors
- Liu, Z., Qiao, D., Xu, Y., Zhao, W., Yang, Y., Wen, D., Li, X., Nie, X., Dong, Y., Tang, S., Jiang, Y., Wang, Y., Zhao, J., & Xu, Y.
- Affiliations
- Shanxi Medical University (CN)
- Chongqing Public Health Medical Center (CN)
- Chongqing University (CN)
- Corresponding author
- Xu, Yong
- ORCID
- Venue
- Journal of Medical Internet Research
- Publisher
- JMIR Publications Inc.
- Published
- 2021-05-14
- Volume
- 23
- Issue
- 5
- Pages
- e26883
- ISSN
- 1438-8871 (ISSN-L)
- PMC
- PMC8128049
- OpenAlex
- W3159534035
- Cited by
- 169
- References
- 61
- Citations by year
- 2026: 9 · 2025: 40 · 2024: 29 · 2023: 51 · 2022: 31 · 2021: 9
- FWCI
- 26.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Medical Internet Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81601193)
- Shanxi Scholarship Council of China (2015-100)
- Shanxi Medical University (YC1409)
- Shanxi Province Science Foundation for Youths (2015021204)
- Topics
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
- Keywords
- computerized cognitive behavioral therapy, COVID-19 pandemic, depressive symptoms, anxiety symptoms, insomnia, psychological intervention, antiretroviral drugs, antidepressant drug interactions, usual care, Hamilton Depression Rating Scale, Hamilton Anxiety Rating Scale, Zung Self-Rating Depression Scale, Self-Rating Anxiety Scale, Athens Insomnia Scale, sex differences, educational attainment, follow-up outcomes, COVID-19 patients
- MeSH terms
- COVID-19, SARS-CoV-2, Adult, Anxiety, Depression, Female, Humans, Male, Prospective Studies, Cognitive Behavioral Therapy, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
